SIOC 中文
CJOG
Adv search

Chinese Journal of Organic Chemistry >

2019 , Vol. 39 >Issue 12: 3505 - 3515

DOI: https://doi.org/10.6023/cjoc201903072

Design, Synthesis and Evaluation of Novel Tacrine-3-n-butylphthalide Hybrids as Multifunctional Cholinesterase Inhibitors

  • Liu Wandong ,
  • Yang Yu ,
  • Li Jiaming ,
  • Guo Yanyan ,
  • Jin Fan ,
  • Zhang Bin
Expand
  • a College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012;
    b Deparment of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012

Received date: 2019-03-29

  Revised date: 2019-06-17

  Online published: 2019-08-01

Supported by

Project supported by the National Health Commission of "Major New Drug Creation" Scientific and Technological Major Project (No. 2018zx09739-001).

Fold

Abstract

A series of tacrine-3-n-butylphthalide hybrids have been designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The result showed that all the target compounds exhibited inhibitory activity on acetylcholinesterase (AChE) and butylcholinesterase (BuChE). Especially, 3-butyl-6-((7-((1,2,3,4-tetra-hydroacridin-9-yl)amino)heptyl)oxy)isobenzofuran-1(3H)-one (10b) displayed the greatest ability to inhibit AChE (IC50=38.65 nmol·L-1), which was 5-fold greater than that of tacrine (IC50=200.70 nmol·L-1). 3-Butyl-6-((8-((6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)oxy)isobenzofuran-1(3H)-one (10g) displayed the greatest ability to inhibit BuChE (IC50=33.69 nmol·L-1), which was close to tacrine (IC50=27.12 nmol·L-1) and 220-fold greater than that of donepezil (IC50=7530 nmol·L-1). In rat Aβ-induced injury model of hippocampal neurons, the effect of compounds on reactive oxygen species (ROS) levels in rat hippocampal have been evaluated, and the results indicated that most of these compounds had potent inhibitory activity for rat hippocampal neuronal cells secreting ROS induced by Aβ1-42.

Key words： Alzheimer's disease; tacrine; 3-n-butylphthalide; cholinesterase; ROS levels

Cite this article

Liu Wandong , Yang Yu , Li Jiaming , Guo Yanyan , Jin Fan , Zhang Bin . Design, Synthesis and Evaluation of Novel Tacrine-3-n-butylphthalide Hybrids as Multifunctional Cholinesterase Inhibitors[J]. Chinese Journal of Organic Chemistry, 2019 , 39(12) : 3505 -3515 . DOI: 10.6023/cjoc201903072

References

[1] Roberson, E. D.; Mucke, L. Science 2006, 314, 781.
[2] Ulep, M. G.; Saraon, S. K.; Mclea, S. J. Nurse Pract. 2018, 14, 129.
[3] Sun, Y.; Chen, J.; Chen, X.; Huang, L.; Li, X. S. Bioorg. Med. Chem. 2013, 21, 7406.
[4] Ulus, R.; Zengin, K. B.; Gazioğlu, I.; Kaya, M. Bioorg. Chem 2017, 70, 245.
[5] Xie, Q.; Wang, H.; Xia, Z.; Liu, M. Y.; Zhang, W. W.; Wang, X. H.; Fu, W. J. Med. Chem. 2008, 51, 2027.
[6] Bolognesi, M.; Minarini, A.; Rosini, M.; Melchiorre, C. Mini-Rev. Med. Chem. 2008, 8, 960.
[7] Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Science 1991, 253, 872.
[8] Chen, Y.; Sun, J.; Fang, L.; Liu, M.; Peng, S.; Liao, H.; Lehmann, J. J. Med. Chem. 2012, 55, 4309.
[9] Fernández-Bachiller, M.; Pérez, C.; Monjas, L.; Rademann, J.; Rodríguez-Franco, M. I. J. Med. Chem. 2012, 55, 1303.
[10] Roger, M. L; Steven, G. P.; Albert, E. INT. J. Neuropsychoph. 2006, 9, 101.
[11] Shanks, M.; Kivipelto, M.; Bullock, R.; Lane, R. Curr. Med. Res. Opin. 2009, 25, 2439.
[12] Hardy, J.; Selkoe, D. J. Science 2002, 297, 353.
[13] Luo, Z.; Sheng, J.; Sun, Y.; Lu, C. J.; Yan, J.; Liu, A. Q.; Luo, H. B.; Huang, L. J. Med. Chem. 2013, 56, 9089.
[14] Jarrott, B. Pharmacol. Res. 2017, 116, 29
[15] Xie, S. S.; Wang, X. B.; Li, J. Y.; Yang, L.; Kong, L. Y. Eur. J. Med. Chem. 2013, 64, 540.
[16] Li, S. Y.; Wang, X. B.; Xie, S. S.; Jiang, N.; Wang, K. D. G.; Yao, H. Q.; Sun, H. B. Eur. J. Med. Chem. 2013, 69, 632.
[17] Zhang, P.; Guo, Z. F.; Xu, Y. M.; Li, Y. S.; Song, J. G. Biomed. Pharmacother. 2016, 83, 658.
[18] Sun, B.; Feng, M.; Tian, X.; Liu, X. W.; Zhang, Y. Y.; Ke, X. J.; Huang, S. S. Neurosci. Lett. 2012, 516; 247.
[19] Peng, Y.; Hu, Y.; Xu, S.; Li, P.; Li, J.; Lu, L.; Yang, H. J. Alzheimers. Dis. 2012, 29, 379.
[20] Carlier, P. R.; Han, Y. F.; Chow, E. S. H.; Li, C. P-L.; Wang, H.; Lieu, T. X.; Wong, H. S. Bioorg. Med. Chem. 1999, 7, 351.
[21] Ellaman, G. Biochem. Pharmacol. 1961, 7, 88.
[22] Lawler, J. M.; Song, W.; Demaree, S. R. Free. Radic. Biol. Med. 2003, 35, 9.
[23] Wang, X.; Wang, L.; Huang, Z.; Huang, Z. J.; Sheng, X.; Li, T. T.; Ji, H. Bioorg. Med. Chem. Lett. 2013, 23, 198.
[24] McKenna, M. T.; Proctor, G. R.; Young, L. C.; Harvey, A. L. J. Med. Chem. 1997, 40, 3516.
[25] María, I. R.; María, I. F.-B.; Concepción, P. J. Med. Chem. 2006, 49, 459.
[26] Li, X. K.; Wang, H.; Xu, Y. X.; Liu, W. W.; Gong, Q.; Wang, W.; Qiu, X. X. ACS Chem. Neurosci. 2017, 8, 2708.
[27] Kulmacz, R. J.; Lands, W. E. M. Prostaglandins 1983, 25, 531.
[28] Kurumbail, R. G.; Stevens, A. M.; Gierse, J. K.; McDonald, J. J.; Stegeman, R. A.; Pak, J. A.; Gildehaus, D.; Iyashiro, J. M. Nature 1996, 384, 644.
[29] Sawatzky, E.; Wehle, S.; Kling, B.; Wendrich, J.; Bringmann, G.; Sotriffer, C. A.; Heilmann, J.; Decker, M. J. Med. Chem. 2016, 59, 2067
[30] Morris, G. M.; Huey, R.; Olson, A. J. Curr. Protoc. Bioinformatics. 2008, 8, 8.
[31] Lill, M. A.; Danielson, M. L. J. Comput.-Aided Mol. Des. 2011, 25, 13.
Options
Outlines

/

〈 〉